MGTXMeiraGTx Holdings plc
What is the market doing?
No clear lean: rangebound and insiders net selling (often routine).
Rangebound, no clear trend. Price is −10% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 22, 2026; selling is often routine (taxes, diversification).
Moderately shorted, settled Sep 30, 2026, about a week of normal trading to cover. Up 49% since the previous count, up from 4.9% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How MGTX is trading
MeiraGTx Holdings plc is +13% over the past year while the S&P 500 is +16%: 3.0 points behind the market.
1-year return · S&P 500 +16%
- vs 200-day average
- −9.5%
vs 200-day average · below trend, but not far
- RSI (14)
- 32
RSI (14) · neutral
- Below its 52-week high
- 39%
Below its 52-week high
Details›
- Last close2026-10-23
- $9.19
- 1 monthS&P 500 −0.94%
- −17%
- 1 yearS&P 500 +16%
- +13%
- 5 yearsS&P 500 +86%
- −29%
- vs 50-day average$12.14
- −24%
- 52-week high
- $14.96
- 52-week low
- $6.99
- Annualised volatility
- 65%
| Year | Return |
|---|---|
| 2026 (year to date) | +16% |
| 2025 | +31% |
| 2024 | −13% |
| 2023 | +7.7% |
| 2022 | −73% |
| 2021 | +57% |
| 2020 | −24% |
| 2019 | +108% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 8 | 3 of 8 | −1.2% |
| Feb | 8 | 4 of 8 | +3.3% |
| Mar | 8 | 2 of 8 | −5.3% |
| Apr | 8 | 6 of 8 | −1.4% |
| May | 8 | 5 of 8 | +1.3% |
| Jun | 8 | 4 of 8 | +5.9% |
| Jul | 9 | 5 of 9 | +0.88% |
| Aug | 9 | 4 of 9 | −2.2% |
| Sep | 9 | 6 of 9 | −2.6% |
| Oct | 9 | 3 of 9 | +6.0% |
| Nov | 8 | 5 of 8 | +5.1% |
| Dec | 8 | 5 of 8 | +5.4% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.
Biotechnology
Ranks #10 of 194 by RyuScore